Life360 Inc (LIF) Stock News

ALIF Holding, the industrial arm of Nasdaq-listed Robo.ai (AIIO), held a groundbreaking ceremony on September 25 for its first phase industrial complex in Umm Al Quwain, UAE. The project aims to develop sustainable industrial capabilities aligned with Operation 300Bn strategy, with Alif Maritec as the first project to enter Phase 1, focusing on oil leak detection, water quality verification, border security, and AI-powered defense solutions. ALIF Holding targets attracting at least three project companies by end of 2026.

ALIF Holding, the industrial group of Robo.ai (Nasdaq: AIIO), held a groundbreaking ceremony for Phase I of its industrial park in Umm Al Quwain on September 25, 2026. The three-phase project will support advanced manufacturing and develop products for local and international markets, with Alif Maritec expected to be the first tenant. ALIF Holding aims to have at least three project companies operational by end of 2026.

Momentum Technologies, a French deeptech company, presented its LIFEPODS survival capsules at VivaTech and Eurosatory 2026. The company offers two models: the B-01 multi-hazard land capsule and the W-01 floating capsule for climate disasters. The B-01 has entered industrialisation with validated ballistic protection standards, while the W-01 prototype was unveiled for the first time at full scale. Momentum Technologies is pursuing a Seed-Series A funding round between late 2026 and early 2027 to support international expansion.

Aduro Clean Technologies Inc. completed a non-brokered private placement raising CAD $9.16 million (USD $6.56 million) through the sale of 431,884 common shares at CAD $21.20 per share under the LIFE exemption. The company plans to use the net proceeds for technology development, commercialization, working capital, and general corporate purposes. Insider participation occurred in the offering.

Aduro Clean Technologies successfully closed a private placement offering, raising CAD $9.16 million (USD $6.56 million) through the sale of 431,884 common shares at CAD $21.20 per share. The company intends to use the net proceeds for technology development, commercialization, working capital, and general corporate purposes. The offering was conducted under regulatory exemptions in Canadian provinces excluding Quebec, with conditional approval from the Toronto Venture Exchange.

Canadian Life Companies Split Corp. declared its monthly distribution of $0.10000 per Class A share and $0.05833 per Preferred share, payable July 10, 2026. The company invests in a portfolio of four major Canadian life insurance companies and has renewed its at-the-market equity program while receiving TSX acceptance for a normal course issuer bid.

Elicio Therapeutics announced that its Phase 2 AMPLIFY-7P study of ELI-002 7P did not meet the primary disease-free survival endpoint in the intent-to-treat population for adjuvant pancreatic cancer. However, post-hoc analyses showed promising results in the R0 resected patient subgroup (84% of enrolled patients) with a hazard ratio of 0.65 (p=0.048). Strong correlations between mutant KRAS-specific T cell responses and improved outcomes supported the drug's biological activity. The company plans to refine its Phase 3 strategy focusing on R0 resected patients with extended dosing, pending financing.

Edward Smolyansky, largest shareholder and former COO of Lifeway Foods, criticizes the Board's governance, stating the poison pill was only terminated after ISS recommended voting against all directors. He highlights a pattern of reactive governance, the reversal of a board refresh process, and calls for shareholders to vote against incumbent directors at the June 17 Annual Meeting to register dissatisfaction with the Board's conduct.

Atlas Salt Inc. has entered into an agreement with Ventum Financial Corp. and Raymond James Ltd. to raise $10 million through a bought deal private placement of 8.33 million common shares at $1.20 per share. The net proceeds will fund early works, site preparation, engineering, permitting, and project financing for the Great Atlantic Salt Project. The offering is expected to close on June 11, 2026, subject to TSX Venture Exchange approval.

Atlas Salt Inc. announced a $10 million bought deal financing through a firm commitment offering of 8.33 million common shares at $1.20 per share, with underwriters Ventum Financial Corp. and Raymond James Ltd. The proceeds will fund preliminary work, engineering design, permitting, and environmental studies for the Great Atlantic Salt Project, with closing expected around June 11, 2026.

Buscar Company (CGLD) announced significant progress in permitting for its Treasure Canyon Gold Mine project in Plumas County, California. The company has received multiple approvals including a burn permit from the Northern Sierra Air Quality Management District and a Lake and Streambed Alteration Agreement from the California Department of Fish and Wildlife. The project continues advancing through federal and state regulatory reviews with ongoing coordination among agencies.